series-c-plus
Stage
2016
Founded
1
Investors
About
BICO Group AB, formerly known as Cellink, is a bioconvergence company that provides technologies and services to enhance biology research. The company specializes in bioprinting, cell line development, and high-throughput drug screening, enabling researchers to culture cells in 3D, print human tissues, and perform drug testing more efficiently.
Explore $BICO's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.